The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2002

Filed:

Feb. 29, 2000
Applicant:
Inventors:

Eugene Metchetner, Palo Alto, CA (US);

Igor B. Roninson, Wilmette, IL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 1/600 ; C07K 1/00 ; C07K 1/400 ; C07K 1/700 ; C12P 2/108 ; A61K 3/9395 ; C12N 5/06 ; C12N 5/16 ;
U.S. Cl.
CPC ...
C07K 1/600 ; C07K 1/00 ; C07K 1/400 ; C07K 1/700 ; C12P 2/108 ; A61K 3/9395 ; C12N 5/06 ; C12N 5/16 ;
Abstract

A hybridoma (termed “UIC2 hybridoma”, ATCC Accession No. HB11027) producing monoclonal antibodies (termed “UIC2 mAb”) directed against an extracellular domain of a cell surface P-glycoprotein antigen associated with multidrug resistance in primate cells was produced by fusing a human myeloma cell with a spleen cell derived from a BALB/c mouse immunized with syngeneic 3T3 fibroblasts previously transfected with the isolated human mdrl cDNA. UIC2 mAb, thus produced, as well as fragments and recombinant derivatives thereof, may be used to detect and isolate multidrug resistant primate cells and human mdrl gene products, and to reverse multidrug resistance in primate cells, including cells of multidrug resistant human tumors.


Find Patent Forward Citations

Loading…